Scioto Biosciences

United States
Indianapolis, Indiana, United States, 46202

Company profile

Scioto Biosciences company profile

Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.

Business identity

Phone number
+1 866 672 4686
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
46202
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$28.3M
Last funding
Series B / $26.5M / 2020-08-10
Last equity funding
Series B / $26.5M
Investors
7
Lead investors
4
Founders
2
Articles
9

Founders and investors

Founders

James SchulzJoseph Trebley

Lead investors

BioCrossroadsElevate VenturesGenome & Co.National Institutes of Health

Investors

BioCrossroadsElevate VenturesGenome & Co.National Institutes of HealthRev1 Ventures